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Metabolic insult results in apoptosis and depletion of mature
oligodendrocytes during demyelination. To examine the role of
insulin-like growth factor-1 (IGF-1) during acute demyelination
and remyelination in the adult CNS, we exposed transgenic mice
that continuously express IGF-1 (IGF-1 tg) to cuprizone intoxica-
tion. Demyelination was observed within the corpus callosum in
both wild-type and IGF-1 tg mice 3 weeks after exposure to
cuprizone. Wild-type mice showed significant apoptotic mature
oligodendrocytes and a dramatic loss of these cells within the
lesion that resulted in near complete depletion and demyelination
by week 5. In contrast, the demyelinated corpus callosum of the
IGF-1 tg mice was near full recovery by week 5. This rapid
recovery was apparently caused by survival of the mature oligo-
dendrocyte population because apoptosis was negligible, and by
week 4, the mature oligodendrocyte population was completely
restored. Furthermore, despite demyelination in both wild-type
and IGF-1 tg mice, oligodendrocyte progenitors accumulated
only in the absence of mature oligodendrocytes and failed to
accumulate if the mature oligodendrocytes remained as demon-
strated in the IGF-1 tg mice. These results suggest that IGF-1
may be important in preventing the depletion of mature oligo-
dendrocytes in vivo and thus facilitates an early recovery from
demyelination.
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The terminal fate of demyelinating disorders is thought to be a
consequence of oligodendrocyte and/or axonal depletion (Comp-
ston, 1996). Previous studies suggest that chronic demyelination
results from the depletion of the mature oligodendrocytes within a
lesion (Johnson and Ludwin, 1981; Mason et al., 2000) (for review,
see Raine, 1997). This depletion of the mature oligodendrocytes
appears to be caused by the apoptotic death of these cells (Pender
et al., 1991; Taniike et al., 1999; Mason et al., 2000). The inhibition
of oligodendrocyte death during primary demyelination, therefore,
may be critical in preventing the progression of a demyelinating
disease to a chronic state.
Insulin-like growth factor 1 (IGF-1) has been shown to induce
myelination in vitro (Mozell and McMorris, 1991) and in vivo (for
review, see D’Ercole et al., 1996; Werther et al., 1998) while also
protecting mature oligodendrocytes from a pathological insult.
IGF-1 has been demonstrated to reduce lesion severity and clinical
deficits in experimental autoimmune encephalomyelitis (EAE)
(Yao et al., 1995, 1996). Furthermore, IGF-1 promotes the long-
term survival of mature oligodendrocytes in culture (Barres et al.,
1993) and inhibits mature oligodendrocyte apoptosis in vitro (Cho
et al., 1997; Ye and D’Ercole, 1999). However, it is not known
whether IGF-1 can inhibit mature oligodendrocyte apoptosis in
vivo after a demyelinating insult.
In this study, we used a transgenic line of mice expressing high
levels of IGF-1 within the brain (IGF-1 tg mice) (Ye et al., 1995) to
investigate whether IGF-1 can protect mature oligodendrocytes
from apoptotic death during primary demyelination in vivo. During
cuprizone intoxication, acute demyelination occurs within the CNS
(Hiremath et al., 1998) that features mature oligodendrocyte apo-
ptosis and subsequent depletion of mature oligodendrocytes from
the corpus callosum (Mason et al., 2000). Although acute demyeli-
nation was observed in both cuprizone-treated wild-type and
IGF-1 tg mice, mature oligodendrocyte death was predominantly
observed in the wild-type mice and infrequently detected in the
IGF-1 tg mice. Furthermore, an early recovery from demyelination
was observed in IGF-1 tg mice. These results suggest that IGF-1
may enhance the recovery from a demyelinating insult presumably
by retaining the mature oligodendrocyte population.
MATERIALS AND METHODS
Induction of demyelination. C57BL/6J wild-type mice (Jackson Laboratory,
Bar Harbor, ME) and IGF-1 tg mice were maintained in our colony. The
IGF-1 tg mice express IGF-1 under the mouse metallothionein-I promoter,
and these mice were backcrossed more than six generations onto the
C57BL/6 background (Ye et al., 1995). At 8 weeks of age, mice were fed
a diet containing 0.2% cuprizone (Sigma, St. Louis, MO) for 5 weeks to
induce demyelination, as described previously (Hiremath et al., 1998).
Sham and cuprizone-treated mice were killed weekly. The forebrains from
the mice were removed for morphological and biochemical analysis as
described previously (Coetzee et al., 1996; Ye et al., 1996; Mason et al.,
2000). Mice were maintained in sterile pathogen-free conditions under
Institutional Animal Care and Use Committee and University of North
Carolina Division of Laboratory Animal Medicine guidelines.
Immunohistochemistry. All comparative analyses were focused in the
corpus callosum on either side near midline. Frozen (10 mm) or paraffin-
embedded (5 mm) brain samples were cut in serial sections between 220
and 260 in the mouse brain atlas (Sidman et al., 1971). Frozen sections
were stained either for IGF-1 using a rabbit anti-IGF-1 antibody (a gift
from Dr. Underwood, Chapel Hill, NC) or for oligodendrocyte progenitors
using a rabbit anti-NG2 antibody (a gift from Dr. Stallcup, San Diego, CA)
as described previously (Mason et al., 2000). No positive cell staining was
observed in tissue sections incubated with a control isotype-matched
antibody (rabbit IgG; Vector Laboratories, Burlingame, CA) in place of
the primary antibody.
Paraffin-embedded sections were stained for the Pi isoform of
glutathione-S-transferase (GST-Pi; a mature oligodendrocyte marker),
GST-Pi /apoptosis (apoptosis was detected using the Neurotacs assay kit
from Trevigen), and Ricinus communis agglutin-1 (RCA-1; a marker for
microglia /macrophages) as described previously (Hiremath et al., 1998;
Morell et al., 1998; Mason et al., 2000).
Cell number quantification. RCA-1 1, GST-Pi 1, GST-Pi /apoptosis 1, and
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NG2 1 cells from three to four mice were quantified as described previ-
ously (Mason et al., 2000). Only positive-stained cells containing a nucleus
were quantified.
Electron microscopy. Glutaraldehyde-fixed brain samples (three mice at
each time point) were prepared as described previously (Coetzee et al.,
1996). Coronal sections (1 mm) were stained with toluidine blue, and the
medial region of the corpus callosum was identified by light microscopy.
The tissue was then trimmed and reoriented for thin sectioning so that
cross sections of the corpus callosum could be examined by electron
microscopy. Thin sections were cut, stained with uranyl acetate and lead
citrate, and photographed, and then the electron micrographs were ana-
lyzed as described previously (Coetzee et al., 1996). Three hundred fibers
(0.3 mm in diameter or greater) from each mouse were examined.
Protein analysis. Total protein was extracted from the forebrains of sham
and treated mice as described previously (Ye et al., 1996). Protein con-
centrations were determined using a protein assay kit (Bio-Rad, Hercules,
CA) with bovine serum albumin as the standard. Quantification of IGF-1
protein was determined by radioimmunoassay as described previously (Ye
et al., 1996) using 20 mg of total protein.
Statistical analysis. Statistical comparisons were made using a one-factor
between-subjects ANOVA, followed by Tukey’s test to assess significance
among groups.
RESULTS
Elevated expression of IGF-1 in transgenic mice
To determine IGF-1 expression in the corpus callosum of wild-type
mice, IGF-1 tg mice, and cuprizone-treated mice, IGF-1 RIA and
immunostaining methods were used. IGF-1 protein levels were
significantly ( p , 0.01) greater in the forebrains of untreated
control IGF-1 tg mice (9.02 6 1.40 ng/mg) compared with wild-type
mice (3.83 6 0.56 ng/mg). This finding correlates with the presence
of IGF-1 immunoreactivity within the corpus callosum of IGF-1 tg
mice compared with the near absence of IGF-11 cells in wild-type
mice (Figs. 1A,B). At 3 weeks of cuprizone exposure, IGF-1
immunoreactivity appeared to slightly increase relative to un-
treated controls in both the wild-type and IGF-1 tg mice (Fig.
1C,D). By 5 weeks, intense IGF-1 immunoreactivity was elevated
for the wild-type mouse compared with untreated control (Fig. 1,
compare A, E). This cellular expression pattern is consistent with
our previous work demonstrating significant increase in IGF-1
protein by 4 and 5 weeks after the onset of mature oligodendrocyte
apoptosis and depletion (Mason et al., 2000). In contrast, the
corpus callosum of IGF-1 tg mice remained immunoreactive at 5
weeks but appeared to display levels similar to that observed in
untreated IGF-1 tg mice (Fig. 1, compare B, F). Nonetheless, IGF-1
persists in the forebrains of IGF-1 tg mice throughout the 5 week
cuprizone treatment period.
Early recovery from acute demyelination in IGF-1
tg mice
Exposing adult mice to cuprizone results in demyelination and
then remyelination of the corpus callosum (Hiremath et al., 1998;
Morell et al., 1998). We examined whether the presence of IGF-1
during the first 5 weeks of cuprizone feeding could alter the
demyelination process. Morphometric analysis demonstrated that
nearly all axons within the corpus callosum were myelinated in both
untreated control wild-type and IGF-1 tg mice (Figs. 2A,B, 3).
After 3 weeks of exposure to cuprizone, the medial region of the
corpus callosum was significantly demyelinated in both the wild-
Figure 1. Presence of IGF-1 within the corpus
callosum of wild-type and IGF-1 tg mice fed cupri-
zone. Frozen brain sections from wild-type (A, C,
E) and IGF-1 tg (B, D, F ) mice were immuno-
stained with anti-IGF-1 ( green). Although few
IGF-1 1 cells were observed within the corpus cal-
losum of the untreated control wild-type mice (A),
a substantial number were observed in the IGF-1 tg
mice (B). At 3 weeks, some IGF-1 1 cells were
present in wild-type mice (C), whereas large num-
bers appeared in the IGF-1 tg mice (D). At 5 weeks,
a large accumulation of IGF-1 1 cells was observed
in the wild-type mice (E), whereas in IGF-1 tg mice
the IGF-1 1 cells appeared similar in number to
untreated control mice. Scale bar, 15 mm.
Figure 2. Demyelination and remyelination in the corpus callosum of
IGF-1 tg and wild-type mice. Electron micrographs show that nearly all
axons within the corpus callosum are myelinated in both the untreated
wild-type (A) and IGF-1 tg (B) mice. A large number of axons are
demyelinated in both the wild-type (C) and IGF-1 tg (D) mice exposed to
cuprizone for 3 weeks. At 5 weeks, almost all of the axons are demyelinated
in the wild-type mice (E), whereas most of the axons are myelinated in the
IGF-1 tg mice ( F). Scale bar, 1.2 mm.
Figure 3. Percentage of myelinated axons within the corpus callosum of
wild-type and IGF-1 tg mice. The percentage of myelinated axons within
the corpus callosum of mice was determined by morphometric analysis of
electron micrographs (300 axons per mouse were examined). The mean and
SEM bars are plotted for each time point (n 5 3) as examined in the
wild-type (black bars) and IGF-1 tg (white bars) mice. (*p , 0.01; **p ,
0.001 when comparing wild-type mice with IGF-1 tg mice.)
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type and IGF-1 tg mice (Figs. 2C,D, 3). In wild-type mice, this
continued until demyelination was nearly complete at week 5 (Figs.
2E, 3). In contrast, the medial region of the corpus callosum was
substantially remyelinated in the IGF-1 tg mice at 5 weeks (Figs.
2F, 3). These results suggest that the demyelinating insult was not
as extensive in the IGF-1 tg mice and that the recovery from the




The accumulation of microglia/macrophages has been shown to be
associated with demyelinating lesions in the CNS of adult mice
(Hiremath et al., 1998). Microglia/macrophages (RCA-11 cells)
were very rare within the corpus callosum of untreated wild-type
and IGF-1 tg mice (Figs. 4A,B, 5). By 3 weeks of cuprizone feeding,
microglia/macrophages began to accumulate in large numbers
within the corpus callosum of wild-type mice; however, even larger
numbers accumulated within the demyelinating lesion in the IGF-1
tg mice (Figs. 4C,D, 5). By 5 weeks, very few RCA-1-positive cells
were observed within the remyelinating corpus callosum of the
IGF-1 tg mice, whereas a large number of these cells remained in
the demyelinated corpus callosum of the wild-type mice at 5 weeks
(Fig. 5). These results demonstrate that the presence of microglia/
macrophages correlates closely with the degree of demyelination
within the corpus callosum.
Survival of mature oligodendrocytes
during demyelination
The rapid recovery of the IGF-1 tg mice from demyelination led us
to postulate that the mature oligodendrocytes in the IGF-1 tg mice
may have survived the demyelinating insult. Before treatment,
wild-type and IGF-1 tg mice appeared to have equal numbers of
GST-Pi1 oligodendrocytes within the corpus callosum (Figs. 6A,B,
7A). After 3 weeks of exposure to cuprizone, the number of
GST-Pi1 oligodendrocytes was reduced by .50% in the wild-type
mice (Fig. 6, compare A with C and Fig. 7A), and by week 5 they
were severely depleted (Figs. 6E, 7A). In contrast, only a slight
reduction in the number of mature oligodendrocytes was observed
in the IGF-1 tg mice (Fig. 6, compare B with D and Fig. 7A). The
presence of IGF-1 appeared to allow for the rapid recovery of the
mature oligodendrocyte population, because the number of GST-
Pi1 oligodendrocytes returned to control levels by 4 and 5 weeks in
the IGF-1 tg mice (Figs. 6F, 7A). These results suggest that mature
oligodendrocytes may be protected by the presence of IGF-1 before
and during acute demyelination within the brain.
We have shown previously that the depletion of the GST-Pi1
population during cuprizone-induced demyelination is likely at-
tributable to the apoptotic death of these cells (Mason et al., 2000).
No apoptotic GST-Pi1 oligodendrocytes were observed in un-
treated control wild-type or IGF-1 tg mice (Figs. 6G,H, 7B). At 3
weeks of cuprizone exposure, a large number of GST-Pi1 oligo-
dendrocytes were undergoing apoptosis in the wild-type mice
(Figs. 6 I, 7B). This is consistent with previous findings that most
apoptotic mature oligodendrocytes were observed between weeks 2
and 4 during exposure to cuprizone (Mason et al., 2000). In
contrast, very few apoptotic oligodendrocytes were observed in the
IGF-1 tg mice at week 3 (Figs. 6J, 7B). These results suggest that
the presence of IGF-1 within the CNS before acute demyelination
appeared to keep mature oligodendrocytes from undergoing
apoptosis.
Absence of oligodendrocyte progenitors within the
demyelinating corpus callosum of IGF-1 tg mice
We have demonstrated previously that oligodendrocyte progeni-
tors accumulate and differentiate within lesions that were depleted
of preexisting mature oligodendrocytes, thereby leading to the
repopulation of the mature oligodendrocytes (Mason et al., 2000).
We speculated that the survival of the mature oligodendrocytes
within the demyelinating lesion in the IGF-1 tg mice may inhibit the
Figure 4. Microglia/macrophages associate
with demyelination within the corpus callosum
of cuprizone-treated wild-type and IGF-1 tg
mice. Paraffin-embedded brain sections from
wild-type (A, C) and IGF-1 tg (B, D) mice were
stained with RCA-1. No RCA-1 1 cells were
observed in the untreated control wild-type (A)
and IGF-1 tg (B) mice. Large numbers of
RCA-1 1 cells (brown stain) were present in
wild-type (C) and IGF-1 tg (D) mice fed cupri-
zone for 3 weeks. Scale bar, 25 mm.
Figure 5. The accumulation of microglia/macrophages in the corpus cal-
losum of wild-type and IGF-1 tg mice during cuprizone feeding. The
number of RCA-1 1 cells of wild-type mice (black bars) and IGF-1 tg mice
(white bars) was quantitated in triplicate and plotted as mean 6 SEM (*p ,
0.001 when comparing wild-type mice and IGF-1 tg mice).
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ushering in of oligodendrocyte progenitors, although demyelina-
tion was evident. Before cuprizone treatment, few oligodendrocyte
progenitors were present within the corpus callosum of untreated
control wild-type and IGF-1 tg mice (Figs. 8A,B, 9). However, a
large number of oligodendrocyte progenitors began to accumulate
within the demyelinating corpus callosum in the wild-type mice at
3 weeks and continued to increase during demyelination through
week 5 (Figs. 8C, 9). In contrast, there was no accumulation of
oligodendrocyte progenitors within either the demyelinating cor-
pus callosum at week 3 or the remyelinating corpus callosum at
weeks 4 and 5 in the IGF-1 tg mice (Figs. 8D, 9). These results
suggest that the activation and accumulation of the oligodendro-
Figure 6. Mature oligodendrocytes and apoptosis in the
corpus callosum of wild-type and IGF-1 tg mice. Paraffin-
embedded brain sections were immunostained with anti-
GST-Pi ( green cells; A–J ), and some sections were also
examined for the presence of apoptotic cells (red nuclei;
G–J ). Large numbers of GST-Pi 1 cells were observed in
untreated control wild-type (A) and IGF-1 tg (B) mice. At
3 weeks of exposure to cuprizone, there was a decrease in
the number of GST-Pi 1 cells in wild-type mice (C),
whereas only a slight reduction was observed in the IGF-1
tg mice (D). At 5 weeks, only a few GST-Pi 1 cells were
observed in the wild-type mice (E), whereas normal num-
bers of these cells were observed in the IGF-1 tg mice (F).
No apoptotic cells were observed in the untreated control
wild-type (G) and IGF-1 tg (H ) mice. At 3 weeks, a large
number of apoptotic nuclei colocalized with GST-Pi 1 cells
(arrow) in wild-type mice ( I ), whereas no colocalization
was observed in the IGF-1 tg mice ( J). Scale bar, 25 mm.
Figure 7. Survival of mature oligodendrocytes in IGF-1 tg mice. The number of GST-Pi 1 mature oligodendrocytes (A) and the number of apoptotic
mature oligodendrocytes (B) were quantitated for wild-type mice (black bars) and IGF-1 tg mice (white bars) from triplicate samples and plotted as mean 6
SEM (*p , 0.001 when comparing wild-type mice with IGF-1 tg mice).
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cyte progenitor population may be dependent on the absence of the
mature oligodendrocyte population and not demyelination. In ad-
dition, these results also imply that the surviving mature oligoden-
drocytes in the IGF-1 tg mice most likely permit the early recovery
from demyelination.
DISCUSSION
We have shown previously that mature oligodendrocytes are de-
pleted by apoptosis during cuprizone-induced demyelination (Ma-
son et al., 2000). In the present study, we have demonstrated several
important findings. (1) The presence of IGF-1 before acute demy-
elination in the CNS appears to inhibit the apoptotic death and
depletion of mature oligodendrocytes; (2) significant primary de-
myelination can occur despite survival of the mature oligodendro-
cyte population; (3) mature oligodendrocytes surviving a demyeli-
nating insult appear to retain the ability to remyelinate; (4) the
activation and accumulation of oligodendrocyte progenitors appear
to occur in response to the absence of mature oligodendrocytes and
not demyelination; and (5) the presence of microglia/macrophages
correlates with each of the demyelination profiles for the wild-type
and IGF-1 tg mice.
The present work showed that increased levels of IGF-1 did not
inhibit microglia/macrophage accumulation and acute demyelina-
tion within the corpus callosum after exposure to cuprizone (Figs.
3, 5). In fact, a greater number of microglia/macrophages and a
slightly greater degree of demyelination were observed in the corpus
callosum of IGF-1 tg mice at 3 weeks compared with the wild-type
mice. Our observations are contrary to findings using the EAE
model of demyelination (Liu et al., 1997). In EAE, the accumulation
of macrophages and the induction of demyelination were blocked in
mice given IGF-1 injections before a pathological insult. The authors
attributed this pathological inhibition to the ability of IGF-1 to
reduce the permeability of the blood–brain barrier (BBB) to im-
mune effector cells, particularly T-cells, during EAE (Liu et al.,
1995). This explanation may not be applicable because previous
studies showed that the BBB is not compromised during cuprizone
feeding (Kondo et al., 1987) and that T-cells play no significant role
in cuprizone-induced demyelination (M. M. Hiremath, K. Suzuki,
J.P.-Y. Ting. G. K. Matsushima, unpublished observations). Thus,
effects of IGF-1 on the T-cell population and the BBB may not be
relevant to cuprizone-induced demyelination.
The presence of IGF-1 early in the treatment period enhanced
mature oligodendrocyte survival. However IGF-1 did not prevent
acute demyelination. It is conceivable that the level of IGF-1 in the
IGF-1 tg mice adequately protects the cell body of mature oligo-
dendrocytes from apoptosis; yet, if it is perturbed enough, this may
result in deterioration of the myelin sheath. Alternatively, during
exposure to cuprizone, apoptosis of mature oligodendrocytes may
be secondary to their lost contact with the axon, and IGF-1 may
temporarily substitute for the axonal survival signal. These findings
suggest that myelin pathology and mature oligodendrocyte death
may be independent processes. Nonetheless, increased levels of
IGF-1 appear to have a profound impact on the remyelination
process. Demyelination within wild-type mice progressed and then
peaked at 5 weeks of cuprizone feeding (Figs. 2C,E, 3), whereas
remyelination was observed after 4 and 5 weeks in the IGF-1 tg
mice (Figs. 2D,E, 3). These results support a controversial issue
that the surviving mature oligodendrocytes are capable of remy-
elination. In addition, these finding are consistent with previous
observations in EAE in which systemic injections of IGF-1, intro-
duced after lesion formation, resulted in reduced clinical deficits
and lesion severity while also upregulating the synthesis of myelin
proteins (Yao et al., 1995, 1996). This rapid recovery may have
been caused by an increase in myelin synthesis, the survival of the
mature oligodendrocyte population, or a combination of both.
Previous studies have recognized mature oligodendrocyte deple-
tion as the primary factor in the formation of chronic demyelinat-
ing lesions (Johnson and Ludwin, 1981; for review see Raine, 1997;
Figure 8. Accumulation of oligodendro-
cyte progenitors within the corpus callo-
sum of wild-type but not IGF-1 tg mice
during demyelination. Frozen brain sec-
tions from wild-type (A, C) and IGF-1 tg
(B, D) mice were stained with the anti-
NG2 antibody ( green). Few NG2 1 cells
were observed in the untreated control
wild-type (A) and IGF-1 tg (B) mice. Large
numbers of NG21 cells were present in
wild-type mice exposed to cuprizone for
3 weeks (C). Few NG2 1 cells were ob-
served in the IGF-1 tg mice fed cuprizone
for 3 weeks ( D). Scale bar, 10 mm.
Figure 9. The accumulation of oligodendrocyte progenitors within the
corpus callosum of wild-type and IGF-1 tg mice during cuprizone intoxi-
cation. The total number of NG2 1 cells was quantitated in the corpus
callosum of wild-type mice (white bars) and IGF-1 tg mice (black bars) from
triplicate samples and plotted as mean 6 SEM.
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unpublished observations). We have demonstrated that the deple-
tion of mature oligodendrocytes during cuprizone-induced demy-
elination is attributable to the apoptotic death of these cells (Ma-
son et al., 2000). The present work, which demonstrates the ability
of IGF-1 to inhibit mature oligodendrocyte apoptosis in vivo (Fig.
7B), is consistent with previous in vitro studies (Cho et al., 1997; Ye
and D’Ercole, 1999). Although no or rare apoptotic oligodendro-
cytes were observed, it is plausible that apoptotic cells escaped our
method of detection or sampling interval that could have accounted
for the slight reduction in the mature oligodendrocyte population
in the IGF-1 tg mice at 3 weeks. Similarly, we cannot rule out the
possibility that this reduction in mature oligodendrocytes could be
a consequence of necrosis and/or dedifferentiation. However, our
data suggest that inhibiting the death of mature oligodendrocytes
not only prevents their depletion, but it may prevent the formation
of chronic plaques in demyelinating diseases such as multiple
sclerosis.
IGF-1 tg mice when compared with wild-type mice displayed
dramatic differences in oligodendrocyte progenitor recruitment
after demyelination. Wild-type mice showed an accumulation of
oligodendrocyte progenitors within the demyelinating lesion (Fig.
8) consistent with previous observations in the adult rodent CNS
(Gensert and Goldman, 1997; Keirstead et al., 1998; Mason et al.,
2000). In contrast, there was no accumulation of oligodendrocyte
progenitors within the demyelinating lesion in the IGF-1 tg mice
where mature oligodendrocytes remained present (Fig. 8). These
results suggest that the activation and/or accumulation of oligoden-
drocyte progenitors within a demyelinating lesion may be in re-
sponse to the death or absence of the mature oligodendrocyte
population as observed in wild-type mice and not caused by demy-
elination alone. Furthermore, the surviving mature oligodendro-
cytes within the demyelinated lesion most likely are responsible for
the early remyelination observed in the IGF-1 tg mice. These
results imply that perturbed mature oligodendrocytes regain their
ability to myelinate when protected by the presence of IGF-1. If
IGF-1 is not present at sufficient levels, as appears to be the case in
wild-type mice, before treatment or during the first 2 weeks of
exposure to cuprizone, then mature oligodendrocytes may become
susceptible to an apoptotic death, which eliminates their role in
remyelination. In wild-type mice, exposure to cuprizone results in
oligodendrocyte death that progresses to their near complete de-
pletion from the corpus callosum, and remyelination is primarily
caused by the recruitment of oligodendrocyte progenitors that
eventually repopulate and differentiate within the lesions (Mason
et al., 2000). Our work here implies that mature oligodendrocytes
are capable of substantial remyelination of demyelinated axons.
Combined with previous in vitro (Cho et al., 1997; Ye and
D’Ercole, 1999) and in vivo (Yao et al., 1996; Liu et al., 1997)
studies, the present work strengthens the support for studying the
therapeutic merits of growth factors such as IGF-1 in demyelinat-
ing diseases.
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